3 attractive growth stocks: Veda Group Ltd, PanAust Limited and Sirtex Medical Limited

8,500 points could be a future scenario for the ASX and Veda Group Ltd (ASX:VED), PanAust Limited (ASX:PNA) and Sirtex Medical Limited (ASX:SRX) could help it get there.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

2014 has been an encouraging year for the ASX, with the leading index rising by 6% since the turn of the year to recently surpass its six-year high. However, as The Motley Fool's Bruce Jackson highlighted in a recent article, the leading index reaching 8,500 points is a possibility one day. Here are three stocks that look to have strong growth prospects.

Veda Group Ltd

Veda Group Ltd (ASX: VED) has significantly outperformed the wider index recently. Its shares are up 24% since the turn of the year and the company recently released a very upbeat set of results that blew away market expectations.

Indeed, Veda is forecast to increase EPS at a rapid rate over the next couple of years, with the company's bottom line all set to rise at an annualised rate of 22.6% over the period. This is well ahead of the expected growth rate of the wider index and, despite this, Veda still appears to offer strong growth at a reasonable price.

Although its P/E ratio of 32.2 may initially put off a lot of investors, combining it with such a strong growth rate equates to a price to earnings growth (PEG) ratio of 1.43, which indicates there is more upside ahead.

PanAust Limited

Mining play PanAust Limited (ASX: PNA) also has the potential to help push the ASX to 8,500 points. It is expected to deliver twice the earnings growth rate of Veda over the next two years, with PanAust forecast to increase its bottom line at an annualised rate of 45.1% over the period.

Despite this, PanAust trades on a P/E ratio that seems to be unduly low, with the company having a rating of just 23.5. Indeed, this equates to a PEG ratio of only 0.52, which screams value and shows there could be more share price growth ahead for the company to add to its year-to-date capital gains of 24%.

Sirtex Medical Limited

Medical business Sirtex Medical Limited (ASX: SRX) recently released results that showed yet another year of strong growth, with the company having the potential to grow strongly over the medium term, depending on the outcome of clinical trials.

The trial outcomes could prove to be extremely positive for Sirtex and, looking ahead, the company is due to deliver a stunning rate of earnings growth over the next two years. For instance, EPS is expected to increase at an annualised rate of 44% over the period. As a result, while Sirtex's P/E ratio of 51 may appear high, its PEG ratio of 1.16 could mean more upside is ahead. This could help to push the ASX to the dizzy heights of 8,500 points.

Motley Fool contributor Peter Stephens does not own shares in any of the companies mentioned.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »